SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review
16 references·0 citing·47 second hop
Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review (2011)Cost-Utility Analyses of Diagnostic Labor…Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents (2010)Willingness‐to‐pay for predic…When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology (2010)When is Cancer Care Cost-Effe…The Limits of Cost-Effectiveness Analysis (2009)The Limits of Cost-Effectiven…Expanded Use Of Imaging Technology And The Challenge Of Measuring Value (2008)Expanded Use Of Imaging Techn…Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis (2008)Economic methods for valuing …European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies (2007)European Perspective on the C…Bias in published cost effectiveness studies: systematic review (2006)Bias in published cost effect…Medicare and Cost-Effectiveness Analysis (2005)Medicare and Cost-Effectivene…Evidence based diagnostics (2005)Evidence based diagnosticsEconomic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer. (2005)Economic analysis of targetin…COST-UTILITY ANALYSES IN ORTHOPAEDIC SURGERY (2005)COST-UTILITY ANALYSES IN ORTH…Cost-Effectiveness And Evidence Evaluation As Criteria For Coverage Policy (2004)Cost-Effectiveness And Eviden…Users' Guides to the Medical Literature (1997)Users' Guides to the Medical …Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Economic Analysis of Health Care Technology: A Report on Principles (1995)Economic Analysis of Health C…Communication of ambiguous risk information (1991)Communication of ambiguous ri…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)Recommendations of the Advisory Committee on Immunization Practices (ACIP) (2008)Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists (2010)Is Technological Change In Medicine Worth It? (2001)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)Health Insurers and Medical-Imaging Policy — A Work in Progress (2009)Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006 (2010)Canada: Health System Review. (2013)The Existence of Publication Bias and Risk Factors for Its Occurrence (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost-Effectiveness in Health and Medicine (1996)Dissemination and publication of research findings: an updated review of related biases (2010)Cost: The missing outcome in simulation-based medical education research: A systematic review (2012)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Utilities and Quality-Adjusted Life Years (1989)Cost-effectiveness league tables: More harm than good? (1993)In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)How to read a paper : getting your bearings (deciding what the paper is about) (1997)How to read a paper: Papers that go beyond numbers (qualitative research) (1997)Criteria for evaluating evidence on public health interventions (2002)Risk, Ambiguity, and the Savage Axioms (1961)Statistical Efficiency of Double‐Bounded Dichotomous Choice Contingent Valuation (1991)Assessing the Added Value of Health Technologies: Reconciling Different Perspectives (2012)Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation (2014)Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis (2017)Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses (2001)Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative (2003)A unification of models for meta-analysis of diagnostic accuracy studies (2006)An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary (2008)Metandi: Meta-analysis of Diagnostic Accuracy Using Hierarchical Logistic Regression (2009)Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs (2009)Cost-utility analysis in spine care: a systematic review (2012)Systematic overview of cost–effectiveness thresholds in ten countries across four continents (2015)Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness (2017)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Personalized medicine: Factors influencing reimbursement (2009)Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer (2010)Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization (2010)
this work references cited by second hop

References

  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,828 cited
  • 2008Expanded Use Of Imaging Technology And The Challenge Of Measuring Value443 cited
  • 2006Bias in published cost effectiveness studies: systematic review383 cited
  • 2005Medicare and Cost-Effectiveness Analysis225 cited
  • 2005Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.224 cited
  • 1995Economic Analysis of Health Care Technology: A Report on Principles220 cited
  • 1997Users' Guides to the Medical Literature202 cited
  • 2010When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology183 cited
  • 2005Evidence based diagnostics173 cited
  • 2010Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents141 cited
  • 2008Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis135 cited
  • 2005COST-UTILITY ANALYSES IN ORTHOPAEDIC SURGERY131 cited
  • 2007European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies119 cited
  • 1991Communication of ambiguous risk information102 cited
  • 2009

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

The Limits of Cost-Effectiveness Analysis
92 cited
  • 2004Cost-Effectiveness And Evidence Evaluation As Criteria For Coverage Policy85 cited
  • Cited by

    No citing works inside the corpus for this window.